The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Abstract
Mitochondrial oxidative damage contributes to a range of degenerative diseases. Consequently, the selective inhibition of mitochondrial oxidative damage is a promising therapeutic strategy. One way to do this is to invent antioxidants that are selectively accumulated into mitochondria within patients. Such mitochondria-targeted antioxidants have been developed by conjugating the lipophilic triphenylphosphonium cation to an antioxidant moiety, such as ubiquinol or α-tocopherol. These compounds pass easily through all biological membranes, including the blood-brain barrier, and into muscle cells and thus reach those tissues most affected by mitochondrial oxidative damage. Furthermore, because of their positive charge they are accumulated several-hundredfold within mitochondria driven by the membrane potential, enhancing the protection of mitochondria from oxidative damage. These compounds protect mitochondria from damage following oral delivery and may therefore form the basis for mitochondria-protective therapies. Here we review the background and work to date on this class of mitochondria-targeted antioxidants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MitoQ rapidly crosses the blood– brain barrier and neuronal membranes and concentrates several hundred-fold in mitochondria driven by the high membrane potential across the inner mitochondrial membrane (IMM; Murphy and Smith, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Murphy and Smith, 2007
In the citing paper
“The recently developed, mitochondria-targeted antioxidant MitoQ (mitoquinone mesylate: [10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cycloheexadienlyl) decyl triphenylphosphonium methanesulfonate]) possesses these qualities (James et al., 2005, 2007; Murphy and Smith, 2007).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Murphy and Smith, 2007
In the citing paper
“Although in most cases this semiquinone is rapidly oxidized, its reaction with oxygen leads to superoxide production at this site (567, 678).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [678]
In the citing paper
“Although the majority of electrons entering the ETC ultimately reduce oxygen to water at complex IV, a small proportion (~2–11%) of electrons escape from the chain at complex I or III to generate superoxide (34, 115, 678).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [678]
In the citing paper
“Importantly, specific complex III inhibitors, such as Antimycin A, can stabilize this semiquinone radical, significantly enhancing superoxide production by complex III (678).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [678]
In the citing paper
“Moreover, treatment with MitoQ, a substance known to scavenge matrix mtROS (see Section 6) [314,315], gave contrasting results: only IL-1β cleavage was reduced, whereas TNF and IL-10 levels remained unaltered.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [314]
In the citing paper
“whereas MitoQ is an analog of ubiquinone and prevents lipid peroxidation in mitochondrial membranes [314,315].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [314]
In the citing paper
“MitoTEMPO is a combination of the antioxidant TEMPO attached to the TPP group and hence dismutates O2●− to H2O2 in the mitochondrial matrix [314,391]”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [314]
In the citing paper
“MitoTEMPO and MitoQ both are targeted to and accumulated in mitochondria due to their TPP group.”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [314]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & PASTAN, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,569
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,487
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
Research works printed but not linked: 4
- Nicholls DG, 2002, Bioenergetics 3
- Ross MF, 2005, Biochemistry, 70, 222
- Pletjushkina OY, 2006, Biochemistry, 71, 60
- Calabrese EJ, 2006, Curr. Opin. Drug Discov. Dev, 9, 117
Cited by
Sorted by citations
Items 201–300 of 1,000
Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics
Batinic̈‐Haberle, I., Rajić, Z., Tovmasyan, A. G., Reboucas, J. S., Ye, X., Leong, K. W., Dewhirst, M. W., Vujašković, Ž., Benov, L., & Spasojević, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.046 · Cited by 134
Reddy, P. H., Mańczak, M., & Kandimalla, R. J. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx052 · Cited by 137
Endoplasmic Reticulum-Directed Ratiometric Fluorescent Probe for Quantitive Detection of Basal H2O2
Gao, C., Tian, Y., Zhang, R., Jing, J., & Zhang, X. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b03809 · Cited by 134
Chen, J., Liu, W., Zhou, B., Niu, G., Zhang, H., Wu, J., Wang, Y., Ju, W., & Wang, P. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo400783x · Cited by 133
A mitochondria-targetable fluorescent probe for peroxynitrite: fast response and high selectivity
Zhang, H., Liu, J., Sun, Y., Huo, Y., Li, Y., Liu, W., Wu, X., Zhu, N., Shi, Y., & Guo, W. (2015) · Chemical Communications · doi:10.1039/c4cc09122a · Cited by 133
Sun, X., Chen, H., Gao, R., Qu, Y., Huang, Y., Zhang, N., Hu, S., Fan, F., Zou, Y., Hu, K., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c05286 · Cited by 134
Maroz, A., Anderson, R. F., Smith, R. A. J., & Murphy, M. P. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.033 · Cited by 132
Self-citationDelivery of drugs and macromolecules to the mitochondria for cancer therapy
Lu, P., Bruno, B. J., Rabenau, M., & Lim, C. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.023 · Cited by 133
Lee, C., Park, H., Jeong, H., Lim, J., Lee, A., Cheon, K. Y., Kim, C.-S., Thomas, A. P., Bae, B., Kim, N. D., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511893n · Cited by 132
Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers
Qu, Q., Ma, X., & Zhao, Y. (2015) · Nanoscale · doi:10.1039/c5nr05139h · Cited by 131
Jeong, E. M., Yoon, J., Lim, J., Shin, J., Cho, A. Y., Heo, J., Lee, K. B., Lee, J.-H., Lee, W. J., Kim, H.-J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.007 · Cited by 130
Cochemé, H. M., Logan, A., Prime, T. A., Abakumova, I., Quin, C., McQuaker, S. J., Patel, J. V., Fearnley, I. M., James, A. M., Porteous, C. M., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.035 · Cited by 130
Self-citationMitochondrially targeted anti-cancer agents
Biasutto, L., Dong, L., Zoratti, M., & Neužil, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.06.004 · Cited by 125
Al-Zubaidi, U., Adhikari, D., Çınar, Ö., Zhang, Q.-H., Yuen, W. S., Murphy, M. P., Rombauts, L. J. F., Robker, R. L., & Carroll, J. (2020) · Human Reproduction · doi:10.1093/humrep/deaa300 · Cited by 124
Self-citationA ratiometric two-photon probe for quantitative imaging of mitochondrial pH values
Sarkar, A. R., Heo, C. H., Xu, L., Lee, H. W., Si, H. Y., Byun, J. W., & Kim, H. M. (2015) · Chemical Science · doi:10.1039/c5sc03708e · Cited by 123
Mitochondria: a new therapeutic target in chronic kidney disease
Granata, S., Gassa, A. D., Tomei, P., Lupo, A., & Zaza, G. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0044-z · Cited by 122
Are mitochondria the main contributor of reactive oxygen species in cells?
Zhang, Y., & Wong, H. S. (2021) · Journal of Experimental Biology · doi:10.1242/jeb.221606 · Cited by 128
Porteous, C. M., Logan, A., Evans, C., Ledgerwood, E. C., Menon, D. K., Aigbirhio, F., Smith, R. A. J., & Murphy, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.06.001 · Cited by 121
Self-citationLi, P., Zhang, W., Li, K., Liu, X., Xiao, H., Zhang, W., & Tang, B. (2013) · Analytical Chemistry · doi:10.1021/ac402409m · Cited by 121
Kucharczyk, R., Zick, M., Bietenhader, M., Rak, M., Couplan, E., Blondel, M., Duvezin‐Caubet, S., & di Rago, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.06.012 · Cited by 121
Young, M. L., & Franklin, J. L. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103409 · Cited by 120
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 125
Bai, J., & Lipski, J. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.01.001 · Cited by 120
Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions
Sandhir, R., Yadav, A., Sunkaria, A., & Singhal, N. K. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.08.011 · Cited by 123
Mitochondrial ROS and mitochondria-targeted antioxidants in the aged heart
Bou‐Teen, D., Kaludercic, N., Weissman, D., Turan, B., Maack, C., Lisa, F. D., & Ruiz‐Meana, M. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.043 · Cited by 119
Chalmers, S., Caldwell, S. T., Quin, C., Prime, T. A., James, A. M., Cairns, A. G., Murphy, M. P., McCarron, J. G., & Hartley, R. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2077922 · Cited by 118
Self-citationPharmacological Applications of Antioxidants: Lights and Shadows
Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 119
Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
García‐Escudero, V., Martín-Maestro, P., Perry, G. L., & Ávila, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/162152 · Cited by 120
Marchi, U. D., Biasutto, L., Garbisa, S., Toninello, A., & Zoratti, M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.002 · Cited by 119
Protective effects of Pt-N-C single-atom nanozymes against myocardial ischemia-reperfusion injury
Ye, T., Chen, C., Wang, D., Huang, C., Yan, Z., Chen, Y., Jin, X. J., Wang, X., Ding, X., & Shen, C. (2024) · Nature Communications · doi:10.1038/s41467-024-45927-3 · Cited by 116
Ye, G., Xie, Z., Zeng, H., Wang, P., Li, J., Zheng, G., Wang, S., Cao, Q., Li, M., Liu, W., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02993-x · Cited by 115
Mitochondria Oxidative Stress, Connexin43 Remodeling, and Sudden Arrhythmic Death
Sovari, A. A., Rutledge, C. A., Jeong, E.-M., Dolmatova, E. V., Arasu, D., Liu, H., Vahdani, N., Gu, L., Zandieh, S., Xiao, L., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.976787 · Cited by 114
Role of Mitochondrial Oxidative Stress in Sepsis
Nagar, H., Piao, S., & Kim, C. (2018) · Acute and Critical Care · doi:10.4266/acc.2018.00157 · Cited by 114
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass
Bonda, D., Wang, X., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1424-x · Cited by 114
Mitochondria‐Targeted Antioxidants in the Treatment of Disease
Smith, R. A. J., Adlam, V. J., Blaikie, F. H., Manas, A. B., Porteous, C. M., James, A. M., Ross, M. F., Logan, A., Cochemé, H. M., Trnka, J., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.003 · Cited by 113
Self-citationTurdi, S., Han, X., Huff, A. F., Roe, N. D., Hu, N., Gao, F., & Ren, J. T. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.084 · Cited by 113
RetractedTargeting mitochondria as an anticancer strategy
Dong, L., & Neužil, J. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0412-6 · Cited by 111
Ceylan‐Isik, A. F., Zhao, P., Zhang, B., Xiao, X., Su, G., & Ren, J. T. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.11.003 · Cited by 110
Mitochondria and reperfusion injury of the heart—A holey death but not beyond salvation
Halestrap, A. P. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9206-x · Cited by 111
Zhu, L., Yuan, Z., Simmons, J. T., & Sreenath, K. (2014) · RSC Advances · doi:10.1039/c4ra00354c · Cited by 111
Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View
Filograna, R., Beltramini, M., Bubacco, L., & Bisaglia, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030102718 · Cited by 110
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation
Ho, G., Aird, R. E., Liu, B., Boyapati, R. K., Kennedy, N. A., Dorward, D. A., Noble, C. L., Shimizu, T., Carter, R. N., Chew, E., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.31 · Cited by 113
Scholpa, N. E., & Schnellmann, R. G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244806 · Cited by 111
Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestinePreprint
Cheung, E. C., Lee, P., Ceteci, F., Nixon, C., Blyth, K., Sansom, O. J., & Vousden, K. H. (2015) · Genes & Development · doi:10.1101/gad.271130.115 · Cited by 114
Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
Fujimoto, C., & Yamasoba, T. (2019) · Antioxidants · doi:10.3390/antiox8040109 · Cited by 109
Role of Drp1, a Key Mitochondrial Fission Protein, in Neuropathic Pain
Ferrari, L. F., Chum, A., Bogen, O., Reichling, D. B., & Levine, J. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2223-11.2011 · Cited by 107
Escribano‐López, I., Díaz‐Morales, N., Rovira‐Llopis, S., Marañón, A., Orden, S., Álvarez, Á., Bañuls, C., Rocha, M., Murphy, M. P., Hernández‐Mijares, A., et al. (2016) · Redox Biology · doi:10.1016/j.redox.2016.10.017 · Cited by 107
Self-citationMitochondria-Targeted Antioxidants as Promising Drugs for Treatment of Age-Related Brain Diseases
Skulachev, V. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111391 · Cited by 109
Wani, W. Y., Gudup, S., Sunkaria, A., Bal, A., Singh, P. P., Kandimalla, R. J. L., Sharma, D. R., & Gill, K. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.008 · Cited by 106
Development of mitochondria-targeted derivatives of resveratrol
Biasutto, L., Mattarei, A., Marotta, E., Bradaschia, A., Nicola Sassi, A., Garbisa, S., Zoratti, M., & Paradisi, C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.100 · Cited by 106
Babizhayev, M. A. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1737 · Cited by 106
A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death
Atkinson, J., Kapralov, A. A., Yanamala, N. V. K., Tyurina, Y. Y., Amoscato, A. A., Pearce, L. L., Peterson, J., Huang, Z., Jiang, J., Samhan-Arias, A. K., et al. (2011) · Nature Communications · doi:10.1038/ncomms1499 · Cited by 106
Lim, S., Rashid, M. A., Jang, M., Kim, Y., Won, H., Lee, J., Woo, J., Kim, Y. S., Murphy, M. P., Ali, L., et al. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000335802 · Cited by 107
Self-citationBarrajón‐Catalán, E., Herranz‐López, M., Joven, J., Segura‐Carretero, A., Alonso‐Villaverde, C., Menéndez, J. A., & Micol, V. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_11 · Cited by 106
Dong, L., Jameson, V. J. A., Tilly, D., Procházka, L., Rohlena, J., Vališ, K., Truksa, J., Zobalová, R., Mahdavian, E., Kľučková, K., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.02.032 · Cited by 106
Self-citationZielonka, J., Srinivasan, S., Hardy, M., Ouari, O., López, M., Vasquez-Vivar, J. M., Avadhani, N. G., & Kalyanaraman, B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.013 · Cited by 105
Mitochondrial complex II, a novel target for anti-cancer agents
Kluckova, K., Bezawork-Geleta, A., Rohlena, J., Dong, L., & Neuzil, J. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.015 · Cited by 104
Antioxidant approaches for the treatment of Alzheimer’s disease
Lee, H. P., Zhu, X., Casadesús, G., Castellani, R. J., Nunomura, A., Smith, M. A., Lee, H., & Perry, G. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.74 · Cited by 104
Hakiminia, B., Alikiaii, B., Khorvash, F., & Mousavi, S. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12767 · Cited by 106
Monitoring Intracellular Redox Potential Changes Using SERS Nanosensors
Auchinvole, C., Richardson, P., McGuinnes, C., Mallikarjun, V., Donaldson, K., McNab, H., & Campbell, C. J. (2011) · ACS Nano · doi:10.1021/nn204397q · Cited by 105
Reactive Oxygen Species and the Aging Eye
Babizhayev, M. A., & Yegorov, Y. E. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ea31ff · Cited by 105
Zang, Q. S., Sadek, H. A., Maass, D. L., Martinez, B., Ma, L., Kilgore, J. A., Williams, N. S., Frantz, D. E., Wigginton, J. G., Nwariaku, F. E., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00203.2011 · Cited by 104
Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants
Domenico, F. D., Barone, E., Marzia Perluigi, A., & Butterfield, D. A. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.955853 · Cited by 103
Karwi, Q. G., Bornbaum, J., Boengler, K., Torregrossa, R., Whiteman, M., Wood, M. E., Schulz, R., & Baxter, G. F. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13688 · Cited by 102
Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection
Osborne, N. N., Núñez-Álvarez, C., Joglar, B., & del Olmo-Aguado, S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.032 · Cited by 101
Yang, Z., Wang, J., Ai, S., Sun, J., Mai, X., & Guan, W. (2019) · Theranostics · doi:10.7150/thno.36988 · Cited by 101
Uncoupling proteins in the mitochondrial defense against oxidative stress
Hass, D. T., & Barnstable, C. J. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100941 · Cited by 104
Moving Forwards by Blocking Back-Flow
Pell, V. R., Chouchani, E. T., Murphy, M. P., Brookes, P. S., & Krieg, T. (2016) · Circulation Research · doi:10.1161/circresaha.115.306569 · Cited by 104
Self-citationDevelopment of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100
A Doubly-Quenched Fluorescent Probe for Low-Background Detection of Mitochondrial H2O2
Liu, J., Liang, J., Wu, C., & Zhao, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b01294 · Cited by 100
Nox2 as a potential target of mitochondrial superoxide and its role in endothelial oxidative stress
Nazarewicz, R. R., Dikalova, A., Bikineyeva, A. T., & Dikalov, S. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00063.2013 · Cited by 99
Triphenylphosphonium (TPP)‐Based Antioxidants: A New Perspective on Antioxidant Design
Wang, J., Li, J. Q., Xiao, Y., Fu, B., & Qin, Z. (2020) · ChemMedChem · doi:10.1002/cmdc.201900695 · Cited by 103
Derivatives of Rhodamine 19 as Mild Mitochondria-targeted Cationic Uncouplers
Antonenko, Y. N., Avetisyan, A. V., Cherepanov, D. A., Кнорре, Д. А., Korshunova, G. A., Маркова, О. В., Ojovan, S. M., Perevoshchikova, I. V., Pustovidko, A. V., Rokitskaya, T. I., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212837 · Cited by 98
Peroxynitrite Detoxification and Its Biologic Implications
Trujillo, M., Ferrer-Sueta, G., & Radi, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2060 · Cited by 97
Dual-Targeting Nanosystem for Enhancing Photodynamic Therapy Efficiency
Xu, J., Zeng, F., Wu, H., Yu, C., & Wu, S. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02297 · Cited by 96
Reddy, P. H., Mańczak, M., Yin, X., & Reddy, A. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170988 · Cited by 97
Calvo-Rodríguez, M., Kharitonova, E. K., Snyder, A. C., Hou, S. S., Sanchez-Mico, M. V., Das, S., Fan, Z., Shirani, H., Nilsson, K. P. R., Serrano‐Pozo, A., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00702-2 · Cited by 100
Osborne, N. N., & del Olmo‐Aguado, S. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.002 · Cited by 96
Recent Advances in Thiol and Sulfide Reactive Probes
Wang, K., Peng, H., & Wang, B. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24762 · Cited by 95
Multiphoton Excited Fluorescent Materials for Frequency Upconversion Emission and Fluorescent Probes
Guo, L., & Wong, M. S. (2014) · Advanced Materials · doi:10.1002/adma.201400084 · Cited by 95
A novel SERS nanoprobe for the ratiometric imaging of hydrogen peroxide in living cells
Peng, R., Si, Y., Deng, T., Zheng, J., Li, J., Yang, R., & Tan, W. (2016) · Chemical Communications · doi:10.1039/c6cc03412h · Cited by 96
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 103
Sánchez-Cano, C., Romero‐Canelón, I., Yang, Y., Hands-Portman, I., Bohic, S., Cloetens, P., & Sadler, P. J. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201605911 · Cited by 94
Nuzzo, A. M., Camm, E. J., Sferruzzi-Perri, A. N., Ashmore, T. J., Yung, H. W., Cindrová‐Davies, T., Spiroski, A., Sutherland, M. R., Logan, A., Austin‐Williams, S., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.027 · Cited by 94
Self-citationJara, J. A., Castro-Castillo, V., Saavedra‐Olavarría, J., Peredo-Silva, L., Pavani, M., Jaña, F., Letelier, M. E., Parra, E., Becker, M. I., Morello, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500174v · Cited by 97
Maiti, K. K., Lee, W. S., Takeuchi, T., Watkins, C. L., Fretz, M. M., Kim, D., Futaki, S., Jones, A. T., Kim, K., & Chung, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701346 · Cited by 93
Prime, T. A., Forkink, M., Logan, A., Finichiu, P. G., McLachlan, J., Pun, P. B. L., Koopman, W. J. H., Larsen, L., Latter, M. J., Smith, R. A. J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.033 · Cited by 92
Self-citationLee, C. P., Maksaev, G. I., Jensen, G. S., Murcha, M. W., Wilson, M. E., Fricker, M. D., Hell, R., Haswell, E. S., Millar, A. H., & Sweetlove, L. J. (2016) · The Plant Journal · doi:10.1111/tpj.13301 · Cited by 92
Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain
Rohlena, J., Dong, L.-F., Ralph, S. J., & Neuzil, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3990 · Cited by 91
Park, S., Pekas, E. J., Headid, R. J., Son, W., Wooden, T. K., Song, J., Layec, G., Yadav, S. K., Mishra, P. K., & Pipinos, I. I. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00235.2020 · Cited by 91
Cationic antioxidants as a powerful tool against mitochondrial oxidative stress
Skulachev, V. P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.063 · Cited by 91
Mitochondria and Heart Disease
Griffiths, E. J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_11 · Cited by 91
Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
Sanchez, M. I. G. L., Crowston, J. G., Mackey, D. A., & Trounce, I. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.004 · Cited by 87
Mitochondrial therapeutic interventions in Alzheimer’s disease
Giau, V. V., An, S. S. A., & Hulme, J. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 87
Targeting mitochondria for cancer photodynamic therapy
Yaqoob, M. D., Xu, L., Li, C., Leong, M. M., & Xu, D. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102830 · Cited by 89
Navarro, A., & Boveris, A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.05.002 · Cited by 88
What is “phenoptosis” and how to fight it?
Skulachev, V. P. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912070012 · Cited by 90
Antonenko, Y. N., Roginsky, V. A., Pashkovskaya, A. A., Rokitskaya, T. I., Kotova, Е. А., Zaspa, A. A., Chernyak, B. V., & Skulachev, V. P. (2008) · The Journal of Membrane Biology · doi:10.1007/s00232-008-9108-6 · Cited by 87
Li, G., Lin, Q. R., Ji, L., & Chao, H. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb01251h · Cited by 86
Metadata
- Authors
- Murphy, M. P., & Smith, R. A. J.
- Affiliations
- MRC Mitochondrial Biology Unit (GB)
- University of Otago (NZ)
- ORCID
- Murphy, Michael P.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2007-02-01
- Volume
- 47
- Issue
- 1
- Pages
- 629-656
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2140014506
- Cited by
- 1,173
- References
- 130
- Citations by year
- 2026: 64 · 2025: 62 · 2024: 72 · 2023: 42 · 2022: 65 · 2021: 67 · 2020: 61 · 2019: 57 · 2018: 61 · 2017: 62 · 2016: 67 · 2015: 67 · 2014: 62 · 2013: 59 · 2012: 68
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- mitochondria-targeted antioxidants, triphenylphosphonium cation, lipophilic cations, mitochondrial oxidative damage, ubiquinol, alpha-tocopherol, mitochondrial membrane potential, blood-brain barrier, oral drug delivery, degenerative diseases, mitochondrial protection
- MeSH terms
- Antioxidants, Cations, Drug Carriers, Humans, Membrane Potentials, Mitochondria, Tissue Distribution, Drug Delivery Systems, Reactive Oxygen Species, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review